Diagnostic Solutions Laboratory is now offering the first molecular pathogen profile, the GI Microbial Assay Plus (GI-MAP). The GI-MAP includes the first comprehensive pathogens assay that is FDA approved, the GPP assay by Luminex Corp. The pathogen targets include bacteria, parasites and another first for the market, viruses!
Using the same molecular technology, Diagnostic Solutions has developed assays for microbes that are useful for integrative and functional medicine practitioners. And unlike previous PCR assays, they have fully validated each target organism in our panel, so that you can have confidence in the results. The panel includes opportunistic organisms, normal flora, parasites, and fungi. DNA/PCR techniques also allow for the measurement of antibiotic resistance genes and virulence factors that contribute to pathogenicity. Both are used to help determine clinical significance and the most effective treatments.
Other available stool tests may appear to be DNA-based tests, but they are in fact using Matrix Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) only to identify stool microbes. Their methodologies rely on cultures from stool and are not molecular/PCR based assays. With a culture based test it is not possible to measure strict anaerobes, viruses or virulence factors. They also lack the ability to deliver true quantitation of any of the reported organisms.
Considering the many advances in DNA technology over the past 10 years, and an FDA approved, PCR based technology and assay that is used by major hospital labs, Diagnostic Solutions is offering a revolutionary way of stool testing. The GI-MAP has surpassed the use of cultures and microscopy for stool analysis and assessment of the GI environment. To learn more about the history behind the GI-MAP visit the diagnostic solutions laboratory website HERE.KALISH COMMUNITY MEMBERS: Watch the interview HERE